No Data
No Data
No Data
No Data
No Data
Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK): Net profit of 142 million yuan in the first quarter decreased by 6.41% year-on-year
Gelonghui, April 25丨Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) announced unaudited results for the first quarter of 2024, achieving operating income of 2,475 billion yuan, a year-on-year decrease of 6.25%; net profit attributable to shareholders of listed companies of 142 million yuan, a year-on-year decrease of 6.41%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses of 138 million yuan, a year-on-year decrease of 6.41%; and basic earnings per share of 0.21 yuan.
Gelonghui FinanceApr 25 04:39 ET
山東新華製藥股份:2024年第一季度未經審核的業績
Futu NewsApr 25 04:33 ET · Announcements
Zhitong Hong Kong Stock Investment Calendar | April 25
According to Zhitong Finance App statistics, on April 25, 2024, the investment logs of Hong Kong stock listed companies are as follows: Category: Company Performance Announcement Sun Xintian Green Energy Era Electric Dexin China China Aluminum Sanbao Technology Tiger Pharmaceuticals China Shipbuilding Defense Shandong Xinhua Pharmaceutical Co., Ltd. Gloria Ying 21st Century Education Shareholders' Meeting HPC Juice China Lilang HPC Holdings China Lilang HPC HOLDINGS CITIC Construction Investment Securities Tiger Pharmaceuticals Weihai Bank Jinan Industrial dividend payment Tian'an (excluding Clean Day) Kowloon Group (dividend day) Pacific Shipping (dividend day) Pacific Shipping (dividend day) (Excluding clean days) Pacific Shipping (excluding clean days) Remittance
Zhitong FinanceApr 24 12:00 ET
山東新華製藥股份:2023年年報
Futu NewsApr 24 04:43 ET · Announcements
Xinhua Pharmaceutical (000756.SZ): Pharmaceutical exports to the US and the US account for about 10% of the company's total sales
Gelonghui, April 17 | Xinhua Pharmaceutical (000756.SZ) said on the investor interactive platform that the company's pharmaceutical exports to the US, including the US, account for about 10% of the company's total sales.
Gelonghui FinanceApr 17 03:28 ET
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation
Shandong Xinhua Pharmaceutical (SHE:000756, HKG:0719) said cefaclor capsules, a drug of its unit Shandong Zibo Xinda Pharmaceutical, passed the quality and efficacy evaluation of China's National Medi
MT NewswiresApr 11 04:59 ET
No Data
No Data
whqqq : Will more capital flow into the Hong Kong market after the delisting crisis?
HopelessChi whqqq: future is solid red. must be some amazing news crashing the future of HSI/HST
whqqq HopelessChi: What's the bad news?
海纳百川 whqqq: 市场的恢复需要更长的时间,目前仍以看空为主
whqqq 海纳百川: OKAY...Thank you for your answer